Teladoc CEO leaves company after stock drops 95% from 2021 highs
Jason Gorevic, CEO of Teladoc Scott Mlyn | CNBC Teladoc Health On Friday it announced the sudden departure of CEO…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
Trump says abortion restrictions should be left to states, avoiding a national ban
Former President Donald Trump said Monday that abortion laws should be left to states, many of which have enacted new…
Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59
Respiratory syncytial virus: viral vaccine under investigation Hail | Stock | fake images a vaccine Pfizer showed the potential to…
Denver and its craft breweries embrace non-alcoholic beers and spirits
Denver Beer Co. Courtesy: Denver Beer Co. This story is part of CNBC's new quarterly Cities of Success series, which…
Google partners with Bayer on new artificial intelligence product for radiologists
Google cloud and German healthcare company Bayer announced Tuesday that they are building an AI-powered platform that aims to help…
Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…
Moderna pauses Kenya vaccine plant plans as demand for Covid shots falls
A nurse prepares a dose of the Moderna Covid-19 vaccine at the Oltepesi dispensary in Kajiado, Kenya, on September 9,…
This consumer microbiome startup is betting profits on an artificial intelligence tool
A probiotic cultivation experiment in a laboratory. Future publications | Future publications | fake images Seed Health has been in…
WHO study shows a return of $39 for every dollar invested in the fight against tuberculosis
A relatively modest new investment could generate significant economic and health benefits, with up to $39 in benefits for every…
J&J cell therapy gains advantage over Bristol Myers rival
Jonathan Raá | Nurfoto | fake images Do you think a friend or colleague should receive this newsletter? Share this…